Home > Quotes > CPHD > Company News
CPHD

CEPHEID News Headlines

$38.23
*  
0.03
  negative  
0.08%
Get CPHD Alerts
*Delayed - data as of May 23, 2013 
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Merge Enhances eClinical OS Platform - Analyst Blog
4/10/2013 3:08:33 PM - Zacks.com

Safeway's Blackhawk Settles IPO Price - Analyst Blog
4/9/2013 3:11:13 PM - Zacks.com

Hologic Reiterated at Neutral - Analyst Blog
4/8/2013 3:10:30 PM - Zacks.com

CYBX Resumes Reimbursement Efforts - Analyst Blog
4/8/2013 3:07:35 PM - Zacks.com

Milestone for Accuray TomoTherapy - Analyst Blog
4/5/2013 3:09:37 PM - Zacks.com

Still Neutral on Merge Healthcare - Analyst Blog
4/5/2013 2:07:18 PM - Zacks.com

Mindray to Exhibit at CMEF - Analyst Blog
4/4/2013 2:06:02 PM - Zacks.com

Abiomed Begins Impella RP Trial - Analyst Blog
4/3/2013 9:22:38 AM - Zacks.com

ResMed Protects Patent Landscape - Analyst Blog
4/2/2013 2:18:25 PM - Zacks.com

Zacks Rank #1 Addition for Tuesday - Tale of the Tape
4/2/2013 9:10:16 AM - Zacks.com

Cepheid To Present At Cowen & Co. Conference; Webcast At 8:40 AM ET
3/6/2013 7:40:00 AM - RTT News

Cepheid To Present At Raymond James Investor Conference; Webcast At 9:15 AM ET
3/5/2013 8:15:00 AM - RTT News

Collaborative Research for Cepheid - Analyst Blog
2/21/2013 3:20:01 PM - Zacks.com

Still Neutral on Cepheid - Analyst Blog
2/12/2013 3:30:01 PM - Zacks.com

Abaxis Surpasses Estimates in 3Q - Analyst Blog
2/1/2013 3:40:01 PM - Zacks.com

All-Front Easy Beat for Covance - Analyst Blog
1/28/2013 9:40:01 AM - Zacks.com

Cepheid Turns to Profit in 4Q - Analyst Blog
1/25/2013 11:50:01 AM - Zacks.com

FDA Categorizes Cepheid's New Test - Analyst Blog
1/16/2013 3:50:01 PM - Zacks.com

Cepheid Unveils Prelim 4Q Results - Analyst Blog
1/10/2013 3:40:01 PM - Zacks.com

Medtech News Over The Christmas Period
1/2/2013 11:57:00 AM - Seeking Alpha

FDA Nod for Cepheid's Latest Test - Analyst Blog
12/28/2012 12:40:01 PM - Zacks.com

Time For Hologic To Translate Technology Into Results (HOLX, GE, CPHD, BDX)
11/14/2012 10:39:00 AM - Investopedia

Mixed 2Q for Abaxis - Analyst Blog
10/26/2012 11:29:40 AM - Zacks.com

A Challenging 3Q for Cepheid - Analyst Blog
10/19/2012 11:20:01 AM - Zacks.com

Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers
9/29/2012 4:09:00 AM - Seeking Alpha